Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03516019 · ClinicalTrials.gov registry record · NA
eFHS Messaging Trial
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 650
- Enrollment target
NCT03516019 is a NA study that has completed, run by Boston University. The registered enrollment target is 650 participants.
The verdict
NCT03516019, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
Study Summary
In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device. The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.
Interventions
- OTHER personalized notices
- OTHER standard notices
- OTHER am notices
- OTHER pm notices
- OTHER weekday notices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2018-05-19 |
| Est. Completion | 2019-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03516019
The ClinicalTrials.gov registry entry for NCT03516019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which personalized notices is the first listed.
NCT03516019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03516019 about?
NCT03516019 is a clinical study titled "eFHS Messaging Trial". In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHe...
What is the current status of trial NCT03516019?
This trial is currently completed. It is a NA study. The enrollment target is 650 participants. The study started on 2018-05-19. Estimated completion is 2019-03-23.
What interventions are being tested in trial NCT03516019?
The interventions under investigation include: personalized notices (OTHER), standard notices (OTHER), am notices (OTHER), pm notices (OTHER), weekday notices (OTHER).
Who is sponsoring clinical trial NCT03516019?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.